Skip to Content

Notice

A Performance Test Protocol for Closed System Transfer Devices Used During Pharmacy Compounding and Administration of Hazardous Drugs; Extension of Comment Period

Comments on this document are being accepted at Regulations.gov. Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Start Printed Page 25290Control and Prevention (CDC), Department of Health and Human Services (HHS).

ACTION:

Notice and extension of comment period.

SUMMARY:

On September 15, 2016 the National Institute for Occupational Safety and Health (NIOSH) of the Centers for Disease Control and Prevention (CDC), published a notice in the Federal Register announcing a public meeting and request for public comment on a draft testing protocol.

Written comments were to be received by December 7, 2016. NIOSH initially extended the public comment period to June 7, 2017 [81 FR 88687]. NIOSH is extending the public comment period for a second time to August 30, 2017. The longer timeframe will allow companies to test the protocol with the proposed challenge agents.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Deborah V. Hirst, NIOSH, Alice Hamilton Laboratories, 1090 Tusculum Avenue, MS-R-5, Cincinnati, Ohio 45226, telephone (513) 841-4141 (not a toll free number), Email: DHirst@cdc.gov.

End Further Info

ADDRESSES:

You may submit comments, identified by CDC-2016-0090 and Docket Number NIOSH 288-A, by either of the following two methods:

  • Federal eRulemaking Portal: http://www.regulations.gov. Follow the instructions for submitting comments.
  • Mail: National Institute for Occupational Safety and Health, NIOSH Docket Office, 1090 Tusculum Avenue, MS C-34, Cincinnati, Ohio 45226-1998.
Start Signature

John Howard,

Director, National Institute for Occupational Safety and Health, Centers for Disease Control and Prevention.

End Signature End Preamble

[FR Doc. 2017-11292 Filed 5-31-17; 8:45 am]

BILLING CODE 4163-19-P